Global Burden of Lung Cancer: Prognosis, Symptom Management, And Challenges with Pulmonary Fibrosis
DOI:
https://doi.org/10.22376/ijtos.2024.2.3.8-13Keywords:
Lung Cancer, Pulmonary FibrosisAbstract
Lung cancer represents a significant global health burden, accounting for the highest number of cancer-related deaths worldwide. Despite advancements in treatment modalities, the prognosis remains poor, with a low 5-year survival rate post-diagnosis and substantial mortality within the first year. Patients often experience debilitating symptoms such as fatigue, pain, dyspnea, and coughing, which severely impact their physical and psychological well-being. Pain management is particularly challenging and critical due to its potential leading to depression and anxiety. Lung cancer encompasses histological classifications such as adenocarcinoma, squamous cell carcinoma, large cell carcinoma and small cell lung cancer (SCLC), each with distinctive subtypes. Patients with idiopathic pulmonary fibrosis (IPF) face exacerbated challenges when they also develop lung cancer, impacting their prognosis significantly compared to those with lung cancer alone. The management of pulmonary fibrosis (PF) in lung cancer necessitates a multifaceted approach, incorporating supportive care, pharmacological interventions, and emerging therapies like molecular targeted therapies, gene therapy, and stem cell therapy. This comprehensive management requires collaboration among various healthcare professionals to optimize outcomes and enhance quality of life for affected patients. Despite considerable progress, managing fibrosis in lung cancer remains complex due to its heterogeneous nature and varied progression. Ongoing future research aims to identify biomarkers for early detection, refine treatment strategies, and explore novel therapies through clinical trials. This review highlights lung cancer's global burden, poor prognosis, and severe symptoms impacting patient well-being. It discusses histological types, compounded challenges with IPF, and the need for a multifaceted treatment approach. Emphasis is placed on ongoing research for early detection, refined treatments, and novel therapies to improve outcomes.
References
Schild SE, Tan AD, Wampfler JA, Ross HJ, Yang P, Sloan JA. A new scoring system for predicting survival in patients with non‐small cell lung cancer. Cancer medicine. 2015 Sep;4(9):1334-43.
Wang X, Liu J, Duan H, Wei H, Dong Q, Meng Q. Effects of a symptom cluster management intervention on the symptom cluster of pain-cough-fatigue-shortness of breath-anorexia and quality of life among post-thoracoscopic-surgery patients with lung cancer: A randomized controlled trial.
Rangachari D, Yamaguchi N, VanderLaan PA, Folch E, Mahadevan A, Floyd SR, Uhlmann EJ, Wong ET, Dahlberg SE, Huberman MS, Costa DB. Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers. Lung cancer. 2015 Apr 1;88(1):108-11.
Zhang Y, Wang H, Wang J, Bao L, Wang L, Huo J, Wang X. Global analysis of chromosome 1 genes among patients with lung adenocarcinoma, squamous carcinoma, large-cell carcinoma, small-cell carcinoma, or non-cancer. Cancer and Metastasis Reviews. 2015 Jun; 34:249-64.
Çolak Y, Nordestgaard BG, Afzal S. Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population. European Respiratory Journal. 2020 Sep 1;56(3).
Li H, Ma N, Wang J, Wang Y, Yuan C, Wu J, Luo M, Yang J, Chen J, Shi J, Liu X. Nicotine induces progressive properties of lung adenocarcinoma A549 cells by inhibiting cystic fibrosis transmembrane conductance regulator (CFTR) expression and plasma membrane localization. Technology in cancer research & treatment. 2018 Nov 1; 17:1533033818809984.
Hughes KT, Beasley MB. Pulmonary manifestations of acute lung injury: more than just diffuse alveolar damage. Archives of pathology & laboratory medicine. 2017 Jul 1;141(7):916-22.
Caliò A, Lever V, Rossi A, Gilioli E, Brunelli M, Dubini A, Tomassetti S, Piciucchi S, Nottegar A, Rossi G, Kambouchner M. Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosis. Histopathology. 2017 Nov;71(5):725-35.
Kreuter M, Ehlers-Tenenbaum S, Schaaf M, Oltmanns U, Palmowski K, Hoffmann H, Schnabel PA, Heussel CP, Puderbach M, Herth FJ, Warth A. Treatment and outcome of lung cancer in idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):266-74.
Watanabe N, Taniguchi H, Kondoh Y, Kimura T, Kataoka K, Nishiyama O, Kondo M, Hasegawa Y. Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis. International journal of clinical oncology. 2014 Apr; 19:260-5.
Sheng Y, Gao J, Yin ZZ, Kang J, Kong Y. Dual-drug delivery system based on the hydrogels of alginate and sodium carboxymethyl cellulose for colorectal cancer treatment. Carbohydrate Polymers. 2021 Oct 1; 269:118325.
Wilkie DJ, Huang HY, Reilly N, Cain KC. Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. Journal of pain and symptom management. 2001 Nov 1;22(5):899-910.
Deng HY, Li G, Luo J, Alai G, Zhuo ZG, Lin YD. Novel biologic factors correlated to visceral pleural invasion in early-stage non-small cell lung cancer less than 3 cm. Journal of Thoracic Disease. 2018 Apr;10(4):2357.
Weiss RJ, Wedin R. Surgery for skeletal metastases in lung cancer: complications and survival in 98 patients. Acta orthopaedica. 2011 Feb 1;82(1):96-101.
Mercadante S. Neoplasm-induced pain. InNeurobiology of disease 2007 Jan 1 (pp. 1007-1020). Academic Press.
Chen JY, Qiao K, Liu F, Wu B, Xu X, Jiao GQ, Lu RG, Li HX, Zhao J, Huang J, Yang Y. Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis. Chinese medical journal. 2020 Jun 20;133(12):1390-6.
Vorobjeva N, Prikhodko A, Galkin I, Pletjushkina O, Zinovkin R, Sud’ina G, Chernyak B, Pinegin B. Mitochondrial reactive oxygen species are involved in chemoattractant-induced oxidative burst and degranulation of human neutrophils in vitro. European Journal of Cell Biology. 2017 May 1;96(3):254-65.
Cheresh P, Kim SJ, Tulasiram S, Kamp DW. Oxidative stress and pulmonary fibrosis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2013 Jul 1;1832(7):1028-40.
NSCLC Meta-Analyses Collaborative Group. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. The Lancet. 2010 Apr 10;375(9722):1267-77.
Zafari N, Velayati M, Maftooh M, Khazaei M, Nassiri M, Hassanian SM, Ghayour-Mobarhan M, Ferns GA, Avan A. Mechanism-based pharmacological management of chemotherapy-induced neuropathic pain from preclinical studies to clinical prospective: platinum-based drugs, Taxanes, and Vinca Alkaloids. Current Pharmaceutical Design. 2023 May 1;29(16):1245-65.
Kim HC, Lee S, Song JW. Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients. Scientific reports. 2021 Apr 15;11(1):8312.
Kreuter M, Ehlers-Tenenbaum S, Schaaf M, Oltmanns U, Palmowski K, Hoffmann H, Schnabel PA, Heussel CP, Puderbach M, Herth FJ, Warth A. Treatment and outcome of lung cancer in idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):266-74.
Savin IA, Zenkova MA, Sen’kova AV. Pulmonary fibrosis as a result of acute lung inflammation: molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches. International Journal of Molecular Sciences. 2022 Nov 29;23(23):14959.
Arai YC, Nishihara M, Aono S, Ikemoto T, Suzuki C, Kinoshita A, Ushida T. Pulsed radiofrequency treatment within brachial plexus for the management of intractable neoplastic plexopathic pain. Journal of anesthesia. 2013 Apr; 27:298-301.
Jaeckle KA. Neurologic manifestations of neoplastic and radiation-induced plexopathies. InSeminars in neurology 2010 Jul (Vol. 30, No. 03, pp. 254-262). © Thieme Medical Publishers.
Muenchrath MM, Gilani SO, Christiansen S, Landreth SP, Ricelli LP. Peripheral nerve stimulator placement for neuropathic pain due to brachial plexus invasion by lung cancer: Case report. Interventional Pain Medicine. 2022 Mar 1;1(1):100070.
Jaeckle KA. Neurological manifestations of neoplastic and radiation-induced plexopathies. InSeminars in neurology 2004 Dec (Vol. 24, No. 04, pp. 385-393). Copyright© 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.
Giray E, Albayrak O, Kenis-Coskun O, Yagci I, Gündüz OH. A case report of lumbosacral plexopathy in a patient with a history of sacral chordoma and radiotherapy: Will the detection of myokymia on the EMG help to solve the case? 1. Journal of Back and Musculoskeletal Rehabilitation. 2023 Jan 1;36(1):155-61.
Mehta V. Radiation pneumonitis and pulmonary fibrosis in non–small-cell lung cancer: Pulmonary function, prediction, and prevention. International journal of radiation oncology* biology* physics. 2005 Sep 1;63(1):5-24.
Spagnolo P, Ryerson CJ, Putman R, Oldham J, Salisbury M, Sverzellati N, Valenzuela C, Guler S, Jones S, Wijsenbeek M, Cottin V. Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities. The Lancet Respiratory Medicine. 2021 Sep 1;9(9):1065-76.
Khanna D, Distler O, Cottin V, Brown KK, Chung L, Goldin JG, Matteson EL, Kazerooni EA, Walsh SL, McNitt-Gray M, Maher TM. Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography. Journal of scleroderma and related disorders. 2022 Oct;7(3):168-78.
Li, Q., Lafrance, D., Liberman, M., Leduc, C., Charbonney, E., Titova, P., Manganas, H. and Chassé, M., 2024. Transbronchial Lung Cryobiopsies, Transbronchial Forceps Lung Biopsies, and Surgical Lung Biopsies in Mechanically Ventilated Patients with Acute Hypoxemic Respiratory Failure: A Retrospective Cohort Study. Journal of Intensive Care Medicine, p.08850666241247145.
Mishra Gp, Mulani Jd. Pulmonary Fibrosis. International Journal of Pharma and Bio Sciences. 2010; 1:2.
Finnerty JP, Ponnuswamy A, Dutta P, Abdelaziz A, Kamil H. Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis. BMC Pulmonary Medicine. 2021 Dec 11;21(1):411.
Nair J, Nair A, Veerappan S, Sen D. Translatable gene therapy for lung cancer using Crispr CAS9—an exploratory review. Cancer gene therapy. 2020 Apr;27(3):116-24.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Dr. Anand Mohan Jha, Dr. Anil Kumar, Dr. John Abraham, Huma Firdaus
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
